Modified G-CSF polypeptide
DCFirst Claim
Patent Images
1. A modified G-CSF polypeptide comprising the amino acid sequence shown in SEQ ID NO:
- 2 anda first chemical moiety attached directly to an external loop;
a second chemical moiety attached to the first chemical moiety;
wherein the first chemical moiety is a polysaccharide and the second chemical moiety is polyethelene glycol;
wherein the modified G-CSF polypeptide has ability to selectively stimulate the production of neutrophils; and
wherein the N terminal methionine as set forth in SEQ ID NO;
2 is optional.
0 Assignments
Litigations
0 Petitions
Accused Products
Abstract
The present invention relates to granulocyte colony-stimulating factor (“G-CSF”) hybrid molecules which retain the internal core helices of G-CSF. Also provided are pharmaceutical compositions containing hybrid molecules.
40 Citations
4 Claims
-
1. A modified G-CSF polypeptide comprising the amino acid sequence shown in SEQ ID NO:
- 2 and
a first chemical moiety attached directly to an external loop; a second chemical moiety attached to the first chemical moiety; wherein the first chemical moiety is a polysaccharide and the second chemical moiety is polyethelene glycol; wherein the modified G-CSF polypeptide has ability to selectively stimulate the production of neutrophils; and wherein the N terminal methionine as set forth in SEQ ID NO;
2 is optional. - View Dependent Claims (2, 3, 4)
- 2 and
Specification